Elsevier

Urology

Volume 89, March 2016, Pages 6-7
Urology

Journal Watch
Comparison of Magnetic Resonance/Ultrasound Fusion-Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer

https://doi.org/10.1016/j.urology.2015.10.010Get rights and content

Section snippets

Summary

This is a prospective cohort study comparing transrectal ultrasound (TRUS)-guided 12-core prostate biopsy (standard) to multiparametric magnetic resonance imaging (mpMRI)/TRUS fusion-guided biopsy (targeted) in 1003 men with indications for prostate biopsy. Among the patients, 80.5% had had a prior negative biopsy and patients with a normal mpMRI were excluded. Targeted biopsy of any suspicious lesions was followed by standard random biopsies done by a second operator blinded to the mpMRI

Comment

This study represents by far the largest series in the literature of patients undergoing MR/TRUS fusion biopsy. These results validate many smaller studies in this field that suggest that mpMRI-targeted biopsies identify more intermediate and high-risk disease than standard 12-core biopsy. At the same time, targeted biopsies reduce the detection of clinically insignificant disease. Previously, urologists have performed a second prostate biopsy on men with persistent suspicion for PCa despite a

References (2)

  • J.J. Futterer et al.

    Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature

    Eur Urol

    (2015)
  • B. Turkbey et al.

    PIRADS 2.0: what is new?

    Diagn Interv Radiol

    (2015)

Cited by (0)

Minhaj Siddiqui M., Rais-Bahrami S., Turkbey B., et al.

JAMA 2015;313:390-397.

View full text